Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma

NCT02997358 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Uterine or Soft Tissue Leiomyosarcoma

Interventions

DRUG: Doxorubicin
DRUG: Trabectedin

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris